Abstract
PCV66 - Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have